Experimental Basis for Optimal Regimnes of Hyperthermic Peritoneal Chemotherapy
Temperature exposure reliably inhibits tumor cell potential for proliferation at the temperature of not less than 43 °C only. Temperature regimens recommended for clinical treatment (40–42 °С) have no significant impact on the viability of tumor cells. Tumor growth arrest in murine models was observed only in case of preliminary warming of inoculated cells at a temperature more than 42 °С. Heating tumor cells up to 39 °С and their incubation with anticancer drugs in the mean-effective concentrations enhanced tumor cell sensitivity towards cytotoxic action of activated lymphocytes.
KeywordsHyperthermia Anticancer drugs Cytotoxicity Tumor cells Effectors of antitumor immunity
- 7.Takeda T, Fukunaga K, Miyazawa K, Takahashi T, Takeda H, Takeda Y, Tanigawa K, Morisaki T, Yamamoto I, Hasegawa T (2008) Immuno-cellular therapy-basic and clinical study. Int J Hyperthermia. Gan To Kagaku Ryoho 35(12):2244–2246Google Scholar
- 12.Anisimova NY, Kiselevskiy MV, Abdullaev AG, Malakhova NV, Sitdikova SM, Polotskiy BE, Davydov MM (2016) Effect of hyperthermia on the viability and proliferative activity of tumor cells. Russian Oncol J 21(5):250–252Google Scholar
- 13.Shubina IZ, Bliumenberg AG, Volkov SM, Demidov LV, Kiselevsky MV (2007) Adoptive immunotherapy of malignancies. Vestn Ross Akad Med Nauk 11:9–15Google Scholar
- 14.Shubina IZ, Titov KS, Mikhailova IN, Kiselevsky MV (2014) Looking into the future of immunotherapy or how to find Cinderella? Int J Cancer Prev 6(3–4):413–424Google Scholar